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Abstract
To investigate the diagnostic accuracy of the QuickVueH Influenza A+B rapid test we conducted a prospective observational
study in which this rapid test was compared with a real-time reverse transcription polymerase chain reaction (RT-PCR) for
pandemic influenza A H1N1 (2009) infection in Austrian adults. The sensitivity, specificity, and positive and negative
predictive values of the QuickVue test compared with the RT-PCR were 26% (95% CI 18–35), 98% (95% CI 92–100), 94% (95%
CI 80–99) and 50% (95% CI 42–58), respectively. The prevalence of pandemic H1N1 (2009) virus infection among the 209
patients included in the study was 57%. Our data suggest that a positive QuickVue test provides considerable information
for the diagnosis of pandemic influenza A H1N1 (2009) virus infection in young adults but that a negative QuickVue test
result should, if relevant for patient management or public health measures, be verified using PCR.
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Introduction
Influenza is a seasonal viral infection associated with significant
morbidity and mortality during local outbreaks and epidemics [1].
Early diagnosis is essential for application of preventive strategies
and initiation of antiviral therapy in patients at risk of
complications [2]. Real-time reverse transcription (RT) PCR is
the current method of choice for detection of influenza virus
infection, with a reported sensitivity of 98–100% and a specificity
of 100% [3]. However, RT-PCR is expensive and is rarely
available in the local primary care setting.
For timely diagnosis, physicians rely on point-of-care testing
that is easy to perform and yields results within minutes, thus
commercially available rapid influenza diagnostic tests (RIDTs)
are widely used in the primary care setting. Nevertheless, RIDTs
do not distinguish among influenza A virus subtypes and test
sensitivity might therefore vary [4]. The recent appearance and
spread of novel influenza H1N1 virus has highlighted the need to
evaluate commercially available and widely used RIDTs for their
ability to detect these viral antigens in clinical respiratory
specimens [4].
There have been several studies on the validity of RIDTs for
diagnosis of pandemic influenza A H1N1 (2009) virus. Results
have revealed wide variability, with sensitivities ranging from 10%
to 75% [2,4,5,6,7,8,9,10,11,12]. As with all screening tests, the
positive and negative predictive values (PPVs and NPVs) of RIDTs
depend on the prevalence of the disease in the population being
tested. Further, differences among age groups, differing study
designs and sample sizes, as well as heterogeneous sample
collection, cause difficulties in comparison of such studies [4].
We conducted a prospective observational study to investigate
the performance of the QuickVueH Influenza A+B rapid test
(Quidel Corp., San Diego, CA, USA) in comparison with a real-
time RT-PCR for detection of pandemic influenza A H1N1 (2009)
virus infection in adults during the 2009 H1N1 pandemic in
Austria.
Materials and Methods
Ethics statement
The study protocol was approved by the Ethics Committee of
the Medical University Vienna and the local institutional review
board of the Military Hospital Vienna. Because all samples were
collected as per standard of care for routine diagnostic testing and
all data were analyzed anonymously, the requirement for informed
consent was waived by the institutional review board.
Patients
The study was conducted at the Military Hospital Vienna
during the 2009 influenza pandemic. All patients with clinical
suspicion of pandemic influenza A H1N1 (2009) virus infection
were routinely tested using the QuickVue Influenza A+B rapid test
and RT-PCR. A total of 208 male and one female patient were
included between 20 September 2009 and 26 January 2010. The
mean age of patients with influenza-like illness was 20 years (range
17–38 years).
Clinical samples and viral detection methods
Sample collection and testing with the QuickVue kit was
performed by physicians previously instructed by the hospital’s
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The rapid test was performed with a first respiratory specimen
using the foam swab included in the kit. A second sample for RT-
PCR testing was collected simultaneously using a sterile Dracon
swab.
The rapid tests were performed immediately on-site according
to the manufacturer’s instructions. Samples for RT-PCR testing
were placed in 0.9% sodium chloride solution and immediately
transferred to the Department of Virology, Medical University
Vienna.
Viral RNA was isolated from respiratory specimens using the
QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany).
Reverse transcription was performed using an iScript cDNA
synthesis kit (Bio-Rad, CA, USA) according to the manufacturer’s
instructions.
The real-time PCR was then performed in a LightCycler 480
(Roche Diagnostics, Mannheim, Germany) using Taq Man (R)
Universal PCR Mastermix; using primer H1-1076Fw: 59-CAG
GGA TGG TAG ATG GAT GG-39, H1-1165Rv: 59-TGG CAT
TCT GTG TGC TCT TC-39and probe 1120P: 59 FAM-CAG
GGG TCA GGA TAT GCA GCC G-39TAMRA (primer
positions according to GenBank accession no. FJ966974).
Briefly, 1 ml viral c-DNA was added to the following reaction
mixture: 12,5 ml Taq ManH Universal PCR Mastermix (Applied
Biosystems, USA), 0,4 ml forward primer (25 pmol), 0,4 ml reverse
primer (25 pmol), 0,2 ml probe (10 pmol) and 6,5 ml water. The
cycling conditions were: initial holds at 50uC for 3 min and 95uC
for 10 min followed by 45 cycles at 95uC for 15 s, 55uC for 30 s
and 77uC for 31 s.
For all PCR testing, a cycle threshold (Ct, the cycle count at
which amplified product yielded a detectable fluorescent signal)
,42 was interpreted as positive. Ct values are indicators of the
amount of virus in the specimen, with lower values indicating
higher viral loads.
To exclude false positive results in the QuickVue test due to
seasonal influenza A infection, samples from patients with a
positive QuickVue result for influenza A but a negative RT-PCR
for pandemic influenza A H1N1 (2009) were also checked by PCR
analysis for influenza A viruses (covering all influenza A virus
subtypes) and in addition by subtype specific PCR’s for seasonal
influenza A/H1N1 and A/H3N2 virus [13].
Statistical analysis
Data are presented as mean and range or median and 25–75%
interquartile range. Categorical data are presented as absolute and
relative frequencies. We used logistic regression to estimate the
effect of observation time (date of sample collection during the
pandemic season) on influenza prevalence, including a test for
linearity.
Sensitivity, specificity, predictive values and likelihood ratios
were estimated according to standard definitions, together with
95% confidence intervals based on exact standard errors. We
compared Ct values between rapid test positive and negative
samples using a Mann–Whitney U test.
Stata 11 for Mac (StataCorp, College Station, Tx, USA) was
used for all statistical analyses.
A two-sided p value,0.05 was considered statistically signifi-
cant.
Results
Of the 209 specimens tested, 119 came from patients who had
positive PCR results for pandemic influenza H1N1 (2009) virus.
Among these 119 patients, the QuickVue test was positive in 31
(26%) and negative in 88 (74%) (Table 1). Of 90 specimens
negative in the PCR, two (2%) were positive in the rapid test and
88 (98%) were negative. The overall prevalence of pandemic
H1N1 (2009) virus infection in the 209 samples was 57%. The
frequency of positive results peaked in November 2009. The
proportion of positive rapid test results among all persons tested,
however, decreased with each month from September 2009 to
January 2010 (OR 0.26, 95% CI 0.14–0.51).
Performance of the QuickVue Influenza A+B rapid test
The overall sensitivity, specificity, PPV and NPV of the
QuickVue Influenza A+B rapid test for 2009 (H1N1) influenza
in comparison with RT-PCR are presented in Table 1.
The positive and negative likelihood ratios were 12 and 0.76,
respectively.
Relation between Ct value and rapid test result
Ct values (median 30.5, minimum 20.3, maximum 41.6) were
available for all 119 specimens in which pandemic H1N1 (2009)
virus was detected by the RT-PCR. Among these, the median Ct
value was 31.9 for 88 specimens with a negative QuickVue test
and 28.44 for 31 specimens with a positive test (p,0.001) (Fig. 1).
Thus, samples with higher viral loads were more likely to test
positive by the rapid test.
The percentage of rapid test positives for cycle threshold
categories is presented in figure 2.
Discussion
This study was designed to investigate the diagnostic accuracy of
the QuickVue Influenza A+B rapid test in adults during the 2009
H1N1 pandemic in Austria. Performance of the rapid test was
moderately good, with a low sensitivity (26%) but a high specificity
(98%) in comparison with a real time RT-PCR assay.
Previous studies on the QuickVue test for pandemic influenza A
H1N1 (2009) have found comparable specificities but higher
sensitivities [2,4,7,8,9,10,11,12,14]. In a study on comparative
epidemiology of pandemic and seasonal influenza A in households
performed in Hong Kong a sensitivity of even 80% was reported
[15]. The differences in performance of RIDTs in several studies
might be due to differences in study design, sample size, and
Table 1. Performance of the QuickVue Influenza A+B rapid
test in comparison with RT-PCR in the diagnosis of pandemic
H1N1 (2009) virus infection.
a
Rapid test
positive
Rapid test
negative
PCR positive 31 88 129
PCR negative 28 8 9 0
33 176 209
Prevalence of PCR positives in sample (95% CI) 57% (50–64)
Sensitivity (95% CI) 26.05% (18–35)
Specificity (95% CI) 97.78% (92–100)
Positive predictive value (95% CI) 93.94% (80–99)
Negative predictive value (95% CI) 50.00% (42–58)
Positive likelihood ratio (95% CI) 12.00 (2.88–48)
Negative likelihood ratio (95% CI) 0.76 (0.68–0.85)
aconfidence interval (CI).
doi:10.1371/journal.pone.0028089.t001
Rapid Influenza Test Performance for H1N1
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transport and storage, and differences between individual patients
[9]. The sensitivity found in the present study appears particularly
low, possibly due to the smaller sample sizes in earlier studies or,
more likely, to the different composition of age categories within
our study population. In the present investigation most of the
patients were young adults, the age group most severely affected
during the 2009 H1N1 pandemic. In addition, no children were
enrolled in our study. This is an important point as specimens
taken from children tend to have higher influenza viral loads than
those taken from adults, which results in better overall sensitivity of
RIDTs in specimens from children and makes comparison with
studies in patients of different age groups difficult [4].
The high specificity found in our study population is in line with
most of the previous studies. In the present study, separate samples
were used for the QuickVue test and the RT-PCR, as the swabs
provided in the QuickVue kit are unusable for other diagnostic
purposes once the swab has been inserted into the kit’s testing
solution. This could have led to some discordant results and may
serve as a possible explanation for the observed test specificity of
,100%. However, the recommended sampling procedures were
followed for each test, permitting assessment of the diagnostic
accuracy of the QuickVue test and the RT-PCR in real-world
conditions [7].
The RT-PCR assay used in this study was specific for pandemic
influenza A H1N1 (2009) virus and did not include other influenza
A virus subtypes such as seasonal influenza A H1N1 or H3N2. To
verify the false positive QuickVue results in the two patients with a
positive QuickVue result for influenza A but a negative RT-PCR
for pandemic influenza A H1N1 (2009), the samples of these two
patients were also investigated for other influenza A viruses by
PCR analysis. In both samples no infection with seasonal influenza
A virus was found, which is in line with national surveillance data
demonstrating that the 2009–2010 influenza pandemic in Austria
was driven exclusively by pandemic 2009 (H1N1) virus [16].
Despite the low sensitivity found in our study population,
specificity was high, resulting in an overall high and positive
likelihood ratio. This is important because likelihood ratios are
good summary metrics that provide sensible estimates of test
properties. In addition, likelihood ratios have the advantage of
immediate quantitative clinical utility through direct application of
Bayes’ theorem [17]. As shown in our study population, the
Figure 1. Ct values of respiratory specimens in 119 patients with RT-PCR-confirmed pandemic influenza A H1N1 (2009) virus
infections. Ct values are compared between patients who had positive (Ct median 28.44) and negative (Ct median 31.9) results in the QuickVue
Influenza A+B rapid test (p,0.001). The box shows the median and interquartile range (box length). The whiskers represent minimum/maximum
values. Individual values are presented as circles.
doi:10.1371/journal.pone.0028089.g001
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would be high in a patient with a positive QuickVue test,
indicating that a positive result with this test does not necessarily
need to be confirmed by RT-PCR during influenza outbreaks and
suffices to determine the appropriate course of treatment or other
action.
In contrast, a negative likelihood ratio of 0.76 as a
consequence of the low sensitivity barely alters the probability
of an infection in patients with negative QuickVue results.
Applying a test with a poor negative likelihood ratio in a high
prevalence population underlines the limitations of using RIDTs
alone for management of possible pandemic H1N1 virus
infection. Reliance on falsely negative test results could delay
the diagnosis of H1N1 infection, resulting in inappropriate
exposure of susceptible persons to infected patients and the
withholding of appropriate therapy. Thus, our data support
current opinion that negative RIDT results do not rule out
influenza infection and, if relevant for patient management or
public health measures such as isolation, negative RIDT results
should be confirmed by PCR.
Several reports have found that the sensitivity of an RIDT
declines with decreasing viral load in the specimen [2,4,6,18,19].
Accordingly, we found a higher proportion of positive QuickVue
results in patients with higher viral titres (as determined by low Ct
values).
Our findings demonstrate that although the QuickVue test is
capable of identifying novel influenza H1N1 in respiratory
specimens .70% of infections will be missed, particularly in
specimens with low viral loads.
The limitations of our study should be noted. The study
population in this analysis comprised military personnel and
mainly young adults, and the results should not be extrapolated to
other age groups. Further, although only patients with influenza-
like illness were included, no information was obtained on specific
symptoms, severity of symptoms or time elapsed between symptom
onset and presentation at the hospital. Thus, differences in
performance of the QuickVue test regarding the day of
presentation and individual clinical presentation could not be
determined.
In conclusion, our data suggest that a positive QuickVue test
provides considerable information for the diagnosis of pandemic
influenza A 2009 (H1N1) virus infection in young adults, but that
negative QuickVue results should, if relevant for patient manage-
ment or public health measures, be verified with PCR assay.
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Figure 2. The numbers of specimens with a positive RIDT result were determined within four intervals of cycle threshold (Ct)
values: 20.3–27.1, 27.2–30.3, 30.5–34.8, 34.9–41.6 (quartiles of Ct values).
doi:10.1371/journal.pone.0028089.g002
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